Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06238726 · ClinicalTrials.gov registry record · NA
Nudging Patients to Increase Shingles Vaccination
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 50,786
- Enrollment target
NCT06238726 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 50,786 participants.
The verdict
NCT06238726, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 50,786 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether messages encouraging patients to ask about a Shingrix vaccine at an upcoming appointment will increase Shingrix vaccination rates. The study will also test which of several message versions is most effective.
Interventions
- BEHAVIORAL Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50,786 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06238726
The ClinicalTrials.gov registry entry for NCT06238726 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50,786 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reminder is the first listed.
NCT06238726 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06238726 about?
NCT06238726 is a clinical study titled "Nudging Patients to Increase Shingles Vaccination". The purpose of this study is to test whether messages encouraging patients to ask about a Shingrix vaccine at an upcoming appointment will increase Shingrix vaccination rates. The study will also test which of several message versions is most effective.
What is the current status of trial NCT06238726?
This trial is currently completed. It is a NA study. The enrollment target is 50,786 participants. The study started on 2024-03-25. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT06238726?
The interventions under investigation include: Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT06238726?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.